Search results
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q4 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 2 months agoACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q4 2023 Earnings Call Transcript February 27, 2024 ACADIA...
ACADIA Pharmaceuticals Inc CEO Stephen Davis Sells 17,714 Shares
GuruFocus.com via Yahoo Finance· 1 month agoStephen Davis, the CEO of ACADIA Pharmaceuticals Inc (NASDAQ:ACAD), has sold 17,714 shares of the...
Insider Sell Alert: EVP Brendan Teehan Sells Shares of ACADIA Pharmaceuticals Inc
GuruFocus.com via Yahoo Finance· 5 months agoACADIA Pharmaceuticals Inc (NASDAQ:ACAD), a biopharmaceutical company specializing in the...
ACADIA Pharmaceuticals Inc. Reports Record Revenues in Q3 2023
GuruFocus.com via Yahoo Finance· 6 months agoACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) reported record revenues in Q3 2023, driven by the strong...
ACADIA Pharmaceuticals Inc.'s (NASDAQ:ACAD) Shift From Loss To Profit
Simply Wall St. via Yahoo Finance· 1 year agoACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) is possibly approaching a major achievement in its...
EVP, General Counsel, Secretary Austin Kim Sells 16,369 Shares of ACADIA Pharmaceuticals Inc
GuruFocus.com via Yahoo Finance· 7 months agoOn October 6, 2023, Austin Kim, the Executive Vice President, General Counsel, and Secretary of...
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Shares Fly 25% But Investors Aren't Buying For Growth
Simply Wall St. via Yahoo Finance· 4 months agoACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) shareholders would be excited to see that the share price...
ACADIA Pharmaceuticals Inc.'s (NASDAQ:ACAD) Share Price Is Matching Sentiment Around Its Revenues
Simply Wall St. via Yahoo Finance· 12 months agoYou may think that with a price-to-sales (or "P/S") ratio of 6.9x ACADIA Pharmaceuticals Inc....
Acadia (ACAD) Begins Study on ACP-101 for Hyperphagia in PWS
Zacks via Yahoo Finance· 5 months agoAcadia Pharmaceuticals Inc. ACAD announced that it has initiated a late-stage study evaluating the...
Acadia's (ACAD) Q2 Earnings & Revenues Surpass Estimates
Zacks via Yahoo Finance· 2 years agoAcadia Pharmaceuticals Inc. ACAD reported a second-quarter 2022 loss of 21 cents per share, narrower...